ReSound OMNIA RIE vs Signia Pure C&G BCT IX
Side-by-side HearAdvisor lab results with SoundGrades, expert pick badges, and the same visualizations we use in product reviews.

ReSound OMNIA RIE
The ReSound OMNIA RIE is a premium prescription behind-the-ear hearing aid released in 2022, currently priced at $4,498. In HearAdvisor's lab testing, it earned a B grade with a SoundScore of 3.9/5, ranking #29 of 36 devices in the Prescription Hearing Aid category. This device shows a mixed performance profile in our testing. Its standout strength is speech clarity in quiet environments, scoring 3.7/5—a solid result that sits 0.42 points above the category average. Own-voice comfort also performs above average at 3.0/5, which may appeal to users concerned about how their own voice sounds while wearing hearing aids. However, the OMNIA RIE struggles significantly in challenging listening situations. Speech-in-noise performance scored just 1.0/5, falling 0.96 points below the category average—a notable limitation for users who frequently encounter noisy restaurants, gatherings, or other difficult acoustic environments. Feedback handling, while strong in absolute terms at 4.1/5, also trails the category average by 0.61 points. Music streaming delivers mixed results at 2.7/5, essentially matching the category average. The OMNIA RIE offers versatile connectivity with both iPhone and Android streaming, hands-free calling capability, and the flexibility of both rechargeable and disposable battery options. At its premium price point, however, several competitors in the same price range—including the Phonak Sphere Infinio and Oticon Intent—deliver substantially higher overall scores. This device may suit users who prioritize quiet conversation clarity and own-voice comfort over challenging noise performance.
Choice

Signia Pure C&G BCT IX
The Signia Pure C&G BCT IX is a premium prescription behind-the-ear hearing aid released in 2025, priced at $3,398. In our lab testing, it earned an A grade with a SoundScore of 4.4/5, placing it in the top 39% of the 36 prescription hearing aids we've tested. This device shows notable strengths in speech clarity and own-voice comfort. Speech in quiet scored 3.8/5, which is 0.47 points above the category average—a solid result for everyday conversations. Speech in noise measured 2.5/5, above the category average by 0.58 points, though only mixed in absolute terms, meaning challenging listening environments may still present difficulty. Own-voice comfort is a standout at 3.8/5, a full 1.05 points above average, suggesting reduced occlusion effects that many wearers find bothersome. Feedback handling scored 4.2/5—strong in absolute terms, though 0.51 points below the category average of 4.71/5. Music streaming at 2.7/5 is essentially on par with category average. The device features rechargeable batteries, iPhone and Android streaming, and hands-free functionality. Consumers shopping in this premium price tier should note that several alternatives offer higher overall scores, including the Phonak Sphere Infinio (5.0/5) and Oticon Intent (4.85/5). For those prioritizing own-voice comfort and solid speech performance in quieter settings, the Pure C&G BCT IX delivers, but buyers seeking top-tier noise performance may want to compare options.
We independently review each item we recommend and appreciate your trust and support. When you buy through our links, we may earn a commission. Learn More.
Performance metrics
Scale 1-5 (Tuned)
Lab metric by fit
Scale 1-5 (Tuned)
Speech level
Adjust input dB (Tuned)
Amplification (REIG)
Insertion gain at 65 dB (Tuned)
Fitting configuration for tuned fit